U-Yi Biotech Raises Tens of Millions of RMB in Series A Financing to Expand Serum-Free Culture Media Platform
Details
June 26 2026Haisco Licenses Two Clinical-Stage Small-Molecule Assets to Nuvectis in Deal Worth Up to US$1.46 Billion
Barty Medical Raises Nearly RMB 200 Million in Series D Financing to Accelerate Commercialization of Vascular Interventional Devices
Over US$1 Billion! Eli Lilly Licenses AlzeCure’s Alzheimer’s Small-Molecule Candidate ACD680
KauseuBie Secures Pre-A Financing to Scale Up Al-Driven Synthetic Biology Manufacturing
ADICON and Gan & Lee Pharmaceuticals Join Forces to Advance ICL + CRO Innovation
YolTech Therapeutics Secures Nearly RMB 500 Million Series C Financing to Accelerate In Vivo Gene Editing Pipeline
$3.05 Billion Licensing Deal! Haisco Enters Global Collaboration with Eli Lilly
$180 million Series A – cAMPfield Therapeutics launches as a NewCo focused on inflammation and immunology.
$202 million – Eli Lilly acquires Engage Biologics, a preclinical biotech pioneering non-viral DNA delivery.
